22 - 25 Feb 2026 | Los Angeles

CancerX Partner Program

About this Session:

This curated session in partnership with CancerX, brings together health system leaders, industry partners, innovators, and patient advocates to explore how we move from isolated pilots to scalable, secure, and patient-centered transformation. The focus is not just on innovation — but on how innovation becomes embedded, trusted, and sustained across cancer care systems 8:00 AM - 8:30 AM: Keynote Conversation: Building the Ecosystem: Why Cancer Innovation Requires a Community Cancer innovation is too complex, too regulated, and too urgent to be solved by any single organization. Breakthroughs in AI, diagnostics, care delivery, and patient engagement demand coordinated leadership across health systems, industry, startups, and patient communities. This keynote conversation explores the power of the CancerX ecosystem, a consortium model designed to align stakeholders around shared priorities, trusted governance, and real-world execution. Leaders will discuss why community-based innovation is essential to scaling cancer solutions responsibly, how cross-sector collaboration accelerates adoption, and what it takes to build a durable infrastructure for trust, security, and measurable impact. The future of cancer innovation will not be built in silos. It will be built together. Speakers: - Diana Gelston, Managing Partner and President, Decimal.health - Xavier Avat, Chief Business Officer and EVP, Moffitt Cancer Center - Rasu Shrestha MD,MBA, Chief Innovation & Commercialization Officer and EVP, Advocate Health 8:30 AM - 8:45 AM: Trust as Infrastructure: Unveiling the CancerX Cybersecurity Program As oncology becomes increasingly digital and data-driven, cybersecurity is no longer a back-office concern, it is foundational to patient trust and system resilience. In this fireside conversation, CancerX unveils its new Cybersecurity Program designed to support safe, secure innovation across the cancer ecosystem. Learn how proactive governance, risk management, and cross-sector collaboration are becoming essential enablers of scalable cancer innovation. Speakers: - Kamal Jethwani, MD, MPH, CancerX Lead, VP Digital Innovation, Moffitt Cancer Center - Baxter Lee, MBA , President, Clearwater 8:45 AM - 9:30 AM: From Listening to Leading: Making the Patient Voice Actionable in Cancer Innovation Patient-centered care requires more than feedback — it requires structured integration of patient voice into decision-making. This panel explores how health systems, innovators, and industry partners are operationalizing patient engagement through PFAC models and CAR T-cell therapy to directly inform digital tools, diagnostics, and care pathways. Learn how embedding patient insight upstream improves adoption, strengthens trust, supports equity, and reduces implementation risk, turning lived experience into measurable system impact. Speakers: - Grace Cordovano, Board Certified Patient Advocate, CancerX Fellow - Stacey Stevens, President and CEO, SimBioSys - Anil Saldanha, Chief Innovation Officer, Rush University System for Health